The forecast for the number of persons with viral hepatitis in China from 2024 to 2028 shows a gradual increase. Notably, in 2023, the baseline for this data was not provided; however, from 2024 to 2028, the figures range from 1.3094 million to 1.3386 million persons. The year-on-year growth rates depict a steady increase of approximately 0.5% per annum. Over a five-year period, the compound annual growth rate (CAGR) is consistent, reflecting these small increments in population affected annually.
Key trends to watch for in the future include policy changes in healthcare, advancements in medical treatments and vaccines for viral hepatitis, and potential shifts in public health initiatives aimed at reducing the spread. Monitoring these factors could considerably influence the prevalence rates among the population in China.
